#116Extended selection 101–500
Avidity Biosciences
California
BiologicsRNA and genetic medicines
Manufacturing profile
Biologics
RNA and genetic medicines
Biopharma hub: California
Selection basis
The company is placed in positions 101–500 as a manufacturer, biotech, generics, advanced-therapy company or CDMO with practical relevance to the FUZKK utility catalog.
The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.
Representative manufacturing and QC chain
- 1Cell bank or microbial seed
- 2Upstream culture or fermentation
- 3Clarification and chromatography
- 4UF/DF, formulation and sterile filtration
- 5SEC, CE, LC-MS, ELISA, qPCR and bioassay QC
- 6Template, oligonucleotide or vector starting materials
- 7Synthesis, transcription or delivery-particle preparation
- 8Purification and sequence/identity confirmation
- 9Potency, integrity, impurities and particle analytics
Relevant FUZKK packages
Product/API utilities
Lumex — instrumental QC
LabEx — laboratory QC
Biologic Aggregate Size Quality CheckerCharge Variant CE Quality CheckerProtein Concentration UV Quality CheckerELISA Bioassay Quality CheckerSPR Binding Affinity Quality CheckerEndotoxin Biologic Product Quality CheckerAutomated Sterility Detection Quality CheckerAssay & Impurity HPLC Quality CheckerResidual Solvents GC Quality CheckerWater Content KF Quality Checker
Medical Devices — equipment and software lifecycle
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand to other products and sites.
Mapping boundary
The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.
Methodology